首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1629881

全球電生理學市場 - 2025-2033

Global Electrophysiology Market - 2025-2033

出版日期: 2024年12月30日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2023年，全球電生理學市場規模達82.4億美元，預計2033年將達230億美元，2025-2033年預測期間複合年成長率為10.7%。

電生理學是一個心臟病學領域，透過分析心臟的電活動來診斷和治療異常心律。醫療保健提供者使用心導管和電腦從心臟內部創建心電圖 (EKG) 追蹤和電測量。這項研究有助於識別心跳訊號的問題，這些訊號通常遵循一致的路線。放置在心臟內的感測器比外部電極提供更多資訊。

市場動態：

驅動程式和限制

科技進步的崛起

由於診斷和治療工具的技術進步，全球電生理學市場正在成長。先進的測繪系統、導管設計和機器人輔助程序正在提高心律不整的診斷和治療效率。人工智慧和機器學習正在徹底改變資料分析，實現個人化治療計劃並降低手術風險。無線和小型化設備以及即時監測功能的發展正在擴大電生理學適應症，改善患者治療效果並滿足對微創手術日益成長的需求。

例如，2024 年 1 月，GE HealthCare 推出了帶有 CardioLab EP 記錄系統的 Prucka 3，這是一種尖端的電生理學工具，可幫助臨床醫生診斷和治療心律不整。該系統建立在二十多年的電生理學專業知識之上，提供了全面的繪圖技術生態系統，可在心律不整診斷和治療中進行準確、高效和先進的分析。

缺乏熟練的專業人員

由於需要專業知識的程序複雜性，全球電生理學市場面臨熟練專業人員的嚴重短缺。這，尤其是在發展中地區，可能會阻礙導管消融和電生理測繪系統等先進技術的廣泛採用。這種短缺導致現有專業人員的壓力增加、等待時間更長，並可能損害患者的治療結果。解決此技能差距對於市場成長和先進技術的有效利用至關重要。

An electrophysiology is a cardiology field that analyzes the electrical activity in the heart to diagnose and treat abnormal heart rhythms. Healthcare providers use cardiac catheters and computers to create electrocardiogram (EKG) tracings and electrical measurements from inside the heart. The study helps identify issues with heartbeat signals, which typically follow a consistent route. The sensors placed inside the heart provide more information than external electrodes.

Market Dynamics: Drivers & Restraints

Rise in the Technological Advancements

The global electrophysiology market is growing due to technological advancements in diagnostic and therapeutic tools. Advanced mapping systems, catheter designs, and robotic-assisted procedures are improving cardiac arrhythmia diagnosis and treatment efficiency. Artificial intelligence and machine learning are revolutionizing data analysis, enabling personalized treatment plans and reducing procedural risks. The development of wireless and miniaturized devices and real-time monitoring capabilities is expanding electrophysiology Indications, improving patient outcomes and addressing the growing demand for minimally invasive procedures.

For instance, in January 2024, GE HealthCare has introduced the Prucka 3 with CardioLab EP Recording system, a cutting-edge electrophysiology tool, to aid clinicians in diagnosing and treating cardiac arrhythmias. This system, built on over twenty years of electrophysiology expertise, offers a comprehensive ecosystem of mapping technologies for accurate, efficient, and advanced analytics in cardiac arrhythmia diagnosis and treatment.

Shortage of Skilled Professionals

The global electrophysiology market faces a significant shortage of skilled professionals due to the complexity of procedures requiring specialized expertise. This, especially in developing regions, can hinder the widespread adoption of advanced technologies like catheter-based ablation and electrophysiology mapping systems. This shortage results in increased pressure on existing professionals, longer wait times, and potentially compromised patient outcomes. Addressing this skill gap is crucial for market growth and efficient use of advanced technologies.

Segment Analysis

The global electrophysiology market is segmented based on product type, indication, end user and region.

Product Type:

EP Ablation Catheters segment is expected to dominate the Electrophysiology market share

The EP ablation catheters segment holds a major portion of the electrophysiology market share and is expected to continue to hold a significant portion of the electrophysiology market share during the forecast period.

EP ablation catheters are essential in the global electrophysiology market for treating arrhythmias like atrial fibrillation and ventricular tachycardia. They deliver radiofrequency energy or cryotherapy to specific heart areas, disrupting abnormal electrical pathways. Their growth is driven by the rise in cardiovascular diseases, advancements in catheter technology, and the need for more efficient, safer, and less invasive treatments. Innovations like improved designs, navigation systems, and real-time imaging have made EP ablation catheters a cornerstone in electrophysiology, improving patient outcomes and market expansion.

For instance, in October 2024, Medtronic has received FDA approval for an early feasibility study to evaluate the Affera Mapping and Ablation System with Sphere-9 Catheter for treating sustained ventricular tachycardia (VT), a potentially life-threatening abnormal heart rhythm affecting the lower chamber of the heart. The system is an all-in-one, dual-energy ablation and high-density mapping catheter used in cardiac electrophysiology ablation procedures.

Indication:

Atrial Fibrillation (AF) segment is the fastest-growing segment in Electrophysiology market share

The atrial fibrillation (AF) segment is the fastest-growing segment in the electrophysiology market share and is expected to hold the market share over the forecast period.

Atrial fibrillation (AF) is a rapidly growing cardiovascular condition that demands precise diagnosis and management through electrophysiology procedures like catheter ablation. The increasing prevalence of AF due to aging populations and risk factors like hypertension and diabetes has driven demand for advanced electrophysiology technologies and treatments. The market growth is accelerated by the need for innovative diagnostic tools, ablation catheters, and advanced mapping systems. Improved treatment options like cryoablation and radiofrequency ablation are providing better outcomes for AF patients, making it a central focus within the electrophysiology sector.

For instance, in November 2024, Johnson & Johnson MedTech has received FDA approval for the VARIPULSE Platform, a device designed to treat drug refractory paroxysmal Atrial Fibrillation (AFib). The VARIPULSE Platform combines PFA therapy and advanced mapping with the CARTO 3 System, a leading 3D electroanatomical cardiac mapping system. It is designed for full integration with CARTO.

Geographical Analysis

North America is expected to hold a significant position in the Electrophysiology market share

North America holds a substantial position in the electrophysiology market and is expected to hold most of the market share due to advanced healthcare infrastructure, acquisitions, high healthcare spending, and emphasis on technological innovations. The region's medical device industry invests heavily in research and development for cutting-edge electrophysiology technologies. The increasing prevalence of cardiovascular diseases and aging population drive demand for electrophysiology procedures. North America's skilled healthcare professionals and favourable reimbursement policies further fuel the market's growth.

For instance, in November 2024, Boston Scientific has acquired Cortex, a pioneer in pulsed field ablation (PFA) technology, to enhance its capabilities in electrophysiology and cardiac care solutions. This acquisition is a significant step for Boston Scientific, which aims to refine treatments for heart rhythm disorders, potentially improving patient outcomes.

Moreover, in May 2024, Biosense Webster, part of Johnson & Johnson MedTech, has launched CARTO 3 System Version 8, the latest version of its three-dimensional heart mapping system for cardiac ablation procedures. The software includes new modules like the CARTO ELEVATE Module and CARTOSOUND FAM Module, enhancing efficiency, reproducibility, and accuracy for electrophysiologists treating patients with atrial fibrillation and other arrhythmias.

Europe is growing at the fastest pace in the Electrophysiology market

Europe holds the fastest pace in the electrophysiology market and is expected to hold most of the market share due to ageing population and increasing heart disease incidence. The demand for minimally invasive procedures is increasing due to their effectiveness in treating arrhythmias and other heart conditions. Advanced diagnostic technologies, like catheter-based ablation and mapping systems, are gaining popularity in advanced countries like Germany, France, and the UK. Collaboration between healthcare providers and manufacturers, regulatory support, and a focus on personalized medicine contribute to the market's growth.

For instance, in July 2024, Volta Medical has announced a Joint Development Agreement with GE HealthCare to integrate its Volta AF-Xplorer AI solution with GE HealthCare's Prucka 3 and CardioLab EP Recording system. The goal is to improve performance and streamline workflows for electrophysiologists during catheter ablation procedures for treating atrial fibrillation (AFib), enhancing their efficiency.

Competitive Landscape

The major global players in the Electrophysiology market include Biosense Webster, Inc. (Johnson & Johnson), Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Siemens Healthineers AG, GE HealthCare, Philips Healthcare, Acutus Medical, Inc, Stereotaxis, Inc, MicroPort Scientific Corporation and among others.

Key Developments

In December 2024, Havasu Regional Medical Center, a LifePoint hospital, has launched an electrophysiology program to diagnose and treat heart arrhythmia. The program aims to improve patient outcomes and reduce the stress and financial burden associated with traveling for care. Arrhythmias, which occur when the heart beats too slowly, too fast, or irregularly, affect around 9.5 million people in the US. AFib, the most common type, has a five-fold higher stroke risk in those with AFib compared to those without it.
In October 2024, KIMSHEALTH Trivandrum has inaugurated a state-of-the-art Electrophysiology Lab with advanced 3D mapping technology, inaugurated by Dr. S Somanath, Chairman of ISRO.

Emerging Players

The emerging players in the electrophysiology market include CathRx, Grid Medical, Acutus Medical, CardioFocus, Inc and among others.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global electrophysiology market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Component & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Indication
3.3. Snippet by End User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rise in the Technological Advancements
- 4.1.2. Restraints
  - 4.1.2.1. Shortage of Skilled Professionals
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. By Product Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. EP Ablation Catheters *
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. EP Diagnostic Catheters
6.4. EP Laboratory Devices
6.5. Access Devices
6.6. Others

7. By Indication

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
- 7.1.2. Market Attractiveness Index, By Indication
7.2. Atrial Fibrillation (AF)*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Atrial Flutter
7.4. Atrioventricular Nodal Reentry Tachycardia (AVNRT)
7.5. Ventricular Tachycardia
7.6. Others

8. By End User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 8.1.2. Market Attractiveness Index, By End User
8.2. Hospitals*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Ambulatory Surgical Centers (ASCs)
8.4. Specialized Clinics
8.5. Diagnostic Centers

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. U.S.
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. U.K.
  - 9.3.6.3. France
  - 9.3.6.4. Spain
  - 9.3.6.5. Italy
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. South Korea
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. Biosense Webster, Inc. (Johnson & Johnson)*
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. Abbott Laboratories
11.3. Medtronic plc
11.4. Boston Scientific Corporation
11.5. Siemens Healthineers AG
11.6. GE HealthCare
11.7. Philips Healthcare
11.8. Acutus Medical, Inc.
11.9. Stereotaxis, Inc.
11.10. MicroPort Scientific Corporation

LIST NOT EXHAUSTIVE